A multiomic approach to prediction, causation, and prevention of preterm birth and preeclampsia

A multiomic approach to prediction, causation, and prevention of preterm birth and preeclampsia

Recent advances in both genomics, transcriptomics, and proteomics have allowed for the development of novel technologies with greater capabilities for biomarker profiling and discovery. When coupled with high-content data analysis, these multiomic approaches have allowed researchers to generate high-efficiency data to enable new correlations and insights between the genome, transcriptome, and proteome at a molecular level in health and disease. For example, an area of unmet need where multiomics is poised to impact significantly is pregnancy-related complications, such as preterm birth and preeclampsia. A better understanding of the molecular mechanisms of feto-maternal changes during pregnancy could help save lives and improve birthing processes.

Our distinguished presenters — members of the Gaudillière lab at Stanford University — describe how they employed a translational approach that combines single-cell mass cytometry with high-plex proteomic and metabolomic analyses to study the role of the human immune system in the pathobiology of fundamental clinical problems, including pregnancy pathologies. The presenters also explain how they used novel machine-learning methods to train multiomic models and identify biologically relevant predictive biomarkers to develop robust diagnostics rooted in a precise understanding of underlying pathobiological mechanisms.

Ina Stelzer, PhD Instructor Stanford University

Ina Stelzer, PhD

Instructor
Stanford University

Julien Hedou Data Analyst Stanford University

Julien Hédou, MSc

Data Analyst
Stanford University

Dorien Feyaerts, PhD Postdoctoral Fellow Stanford University

Dorien Feyaerts, PhD

Postdoctoral Fellow
Stanford University

A multiomic approach to prediction, causation, and prevention of preterm birth and preeclampsia

A presentation by Ina Stelzer, PhD, Julien Hédou, MSc, and Dorien Feyaerts, PhD

Share with colleagues

More webinars

WebinarUsing non-hypothesized based approaches for biomarker development

Current biomarkers are only moderately predictive in identifying individuals with mild traumatic brain injury or concussion. Therefore, more accurate diagnostic markers are needed for sport-related concussion (SRC).

Learn more

WebinarAssessment of variability and normalization methods using the plasma 7K SomaScan® Assay v4.1

In this webinar, the speakers present the largest technical assessment of this platform to date based on a study of 2,050 samples across 22 plates.

Learn more

WebinarThe proteomics of aging: how technology is advancing research

Please join us to hear four experts discuss the present challenges and opportunities for proteomics in aging research: Eric Morgen, COO of BioAge Labs; Paola Sebastiani, faculty biostatistician at Tufts Medical Center and PI on the Longevity Consortium; Birgit Schilling, associate professor, Buck Institute for Research on Aging; and Alessandro Ori, group leader at the Leibniz Institute on Aging.

Learn more